Literature DB >> 20226836

Proteome of platelets in patients with coronary artery disease.

Cristina Banfi1, Maura Brioschi, Giancarlo Marenzi, Monica De Metrio, Marina Camera, Luciana Mussoni, Elena Tremoli.   

Abstract

OBJECTIVE: This study aimed at investigating the protein patterns of platelets from patients with stable or acute coronary atherosclerosis (CAD), in which platelets play a key role.
MATERIALS AND METHODS: A proteomic approach was adopted to investigate specific protein patterns in platelets of patients with non-ST elevation acute coronary syndrome, stable angina, or of subjects with no history of CAD.
RESULTS: Six differentially expressed proteins were identified: two involved in energy metabolism (2-oxoglutarate dehydrogenase [OGDH], and lactate dehydrogenase [LDH]); three were associated with cytoskeleton-based processes (gamma-actin, coronin 1B, and pleckstrin); and one involved in protein degradation (proteasome subunit type 8). Expression levels of OGDH and a cleaved form of gamma-actin were significantly higher in the platelets of patients than in controls, whereas that of LDH was higher only in the platelets of patients with acute coronary disease. The increases in protein expression of OGDH and LDH are paralleled by changes in their functional activities. Coronin and proteasome subunit type 8 were less expressed in the platelets of patients, as were the basic isoforms of pleckstrin.
CONCLUSION: The platelet proteome is altered in CAD patients with stable or acute coronary syndrome possibly because of the ongoing atherosclerotic process. The identified protein changes not previously connected with CAD were an increase in the energy metabolism enzymes and alterations in the proteins associated with cytoskeleton-based processes, both of which indicate platelet activation. 2010 ISEH-Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226836     DOI: 10.1016/j.exphem.2010.03.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

1.  Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve.

Authors:  Cristina Banfi; Anna Guarino; Maura Brioschi; Stefania Ghilardi; Valeria Mastrullo; Elena Tremoli; Gianluca Polvani
Journal:  J Vis Exp       Date:  2017-06-14       Impact factor: 1.355

2.  Global proteome analysis identifies active immunoproteasome subunits in human platelets.

Authors:  Cordula Klockenbusch; Geraldine M Walsh; Lyda M Brown; Michael D Hoffman; Vladimir Ignatchenko; Thomas Kislinger; Juergen Kast
Journal:  Mol Cell Proteomics       Date:  2014-08-21       Impact factor: 5.911

3.  Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease.

Authors:  Yue Liu; Hui-jun Yin; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

Review 4.  Protein degradation systems in platelets.

Authors:  B F Kraemer; A S Weyrich; S Lindemann
Journal:  Thromb Haemost       Date:  2013-09-19       Impact factor: 5.249

5.  Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein.

Authors:  Tyler W Jenkins; Sondra L Downey-Kopyscinski; Jennifer L Fields; Gilbert J Rahme; William C Colley; Mark A Israel; Andrey V Maksimenko; Steven N Fiering; Alexei F Kisselev
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

6.  Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies.

Authors:  Yue Liu; Hui-Jun Yin; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-21       Impact factor: 2.629

Review 7.  Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics.

Authors:  Erica Gianazza; Maura Brioschi; Roberta Baetta; Alice Mallia; Cristina Banfi; Elena Tremoli
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

8.  Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients.

Authors:  Michal Bijak; Alicja Olejnik; Bozena Rokita; Agnieszka Morel; Angela Dziedzic; Elzbieta Miller; Joanna Saluk-Bijak
Journal:  J Cell Mol Med       Date:  2019-03-05       Impact factor: 5.310

9.  Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  ScientificWorldJournal       Date:  2014-03-03

10.  Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Authors:  Roseanne Raphael; Diana Purushotham; Courtney Gastonguay; Marla A Chesnik; Wai-Meng Kwok; Hsiang-En Wu; Sanjiv J Shah; Shama P Mirza; Jennifer L Strande
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.